We need your help to discover new safe & effective strategies to prevent HIV! Check out our current studies below & contact us!
Give PrEP A SHOT
Injectable PrEP Study
HPTN 083 tests a new injectable form of PrEP (Pre-Exposure Prophylaxis) called cabotegravir (CAB) and compares it with Truvada to see if CAB is as safe and effective at prevention HIV infection as Truvada.
The study also tests the safety and tolerability of both an oral & injectable form of CAB & seeks to answer the question: " How do people feel about injections versus taking a pill?" If you are accepted into the HPTN 083 study, you will receive study-related exams, lab tests & study medicine at no cost.
INTERESTED IN PARTICIPATING?
EBAC's Clinical Research Team
Clinical Research Nurse|Janet.Han@sutterhealth.org|510-869-8490
Soon to open “An Operationally Seamless Phase 2/3 Randomized, Open-label, Multicenter, Active-Controlled Study to Evaluate the Safety and Efficacy of Bictegravir/Lenacapavir Versus Stable Baseline Regimen in Virologically Suppressed People with HIV-1 on Stable Complex Treatment Regimens” – Principal Investigator -Jeff Burack, MD –
For more info contact Julian at